Life Sciences Tools & Services Stocks
Suppliers of mission-critical infrastructure, analytical instruments, and specialized real estate provide the foundational framework required for pharmaceutical research and clinical diagnostics. Revenue models rely on a mix of high-margin consumables, recurring service contracts, and purpose-built laboratory facilities that face stringent regulatory hurdles and high switching costs.
As of Oct 23, 2026, Life Sciences Tools & Services has 98 US-listed companies worth $1.3T combined. The median member moved +2.5% over the past week; CRL led among the 25 largest at +15.1% and AME trailed at -3.3%.
Companies in Life Sciences Tools & Services
- TMO – Thermo Fisher Scientific Inc, $249B
- DHR – Danaher Corporation, $162B
- ECL – Ecolab Inc, $81.9B
- AME – Ametek Inc, $54.8B
- BDX – Becton Dickinson and Company, $54.6B
- VEEV – Veeva Systems Inc Class A, $52.2B
- A – Agilent Technologies Inc, $48.8B
- IQV – IQVIA Holdings Inc, $45.8B
- WAT – Waters Corporation, $44.9B
- IDXX – IDEXX Laboratories Inc, $44.6B
- VTR – Ventas Inc, $43.8B
- ILMN – Illumina Inc, $40.7B
- MTD – Mettler-Toledo International Inc, $33.5B
- WST – West Pharmaceutical Services Inc, $27.7B
- LH – Laboratory Corporation of America Holdings, $26.7B
- DOV – Dover Corporation, $26.3B
- STE – STERIS plc, $22.6B
- GH – Guardant Health Inc, $21.9B
- RVTY – Revvity Inc., $17.7B
- IEX – IDEX Corporation, $16.7B
- CRL – Charles River Laboratories, $16.6B
- ICLR – ICON PLC, $14.3B
- DOC – Healthpeak Properties Inc, $13.1B
- AVTR – Avantor Inc, $11.7B
- TECH – Bio-Techne Corp, $11.4B
- RGEN – Repligen Corporation, $11.3B
- QGEN – Qiagen NV, $10.4B
- TWST – Twist Bioscience Corp, $9.9B
- TXG – 10X Genomics Inc, $9.8B
- BIO – Bio-Rad Laboratories Inc, $9.6B
- CAI – Caris Life Sciences, Inc. Common Stock, $9B
- BRKR – Bruker Corporation, $8.7B
- SHMXY – Shimadzu Corp, $7.6B
- ARE – Alexandria Real Estate Equities Inc, $7.4B
- TFX – Teleflex Incorporated, $5.5B
- STVN – Stevanato Group SpA, $5.5B
- SHC – Sotera Health Co, $5B
- BLLN – BillionToOne, Inc. Class A Common Stock, $4.8B
- KRC – Kilroy Realty Corp, $4.4B
- ASH – Ashland Global Holdings Inc, $3.4B
- NEOG – Neogen Corporation, $2.6B
- WLYB – John Wiley & Sons B, $2.5B
- MRVI – Maravai Lifesciences Holdings Inc, $2.4B
- FTRE – Fortrea Holdings Inc., $2.1B
- NEO – NeoGenomics Inc, $2.1B
- ALMR – Alamar Biosciences, Inc. Common Stock, $2B
- BLFS – BioLife Solutions Inc, $1.9B
- ATS – ATS Corporation, $1.8B
- SDGR – Schrodinger Inc, $1.7B
- PSNL – Personalis Inc, $1.7B
- AZTA – Azenta Inc, $1.5B
- CERT – Certara Inc, $1.4B
- CYRX – Cryoport Inc, $879M
- TRNS – Transcat Inc, $846M
- CTKB – Cytek Biosciences Inc, $763M
- MLAB – Mesa Laboratories Inc, $722M
- DNA – Ginkgo Bioworks Holdings, $692M
- SOPH – Sophia Genetics SA, $687M
- OABI – OmniAb Inc., $663M
- FLGT – Fulgent Genetics Inc, $591M
- PACB – Pacific Biosciences of California, $572M
- MDRX – Veradigm Inc., $517M
- EVO – Evotec SE ADR, $478M
- TKNO – Alpha Teknova Inc, $468M
- NAUT – Nautilus Biotechnology Inc, $412M
- SLP – Simulations Plus Inc, $374M
- BDSX – Biodesix Inc, $279M
- CLPT – Clearpoint Neuro Inc, $277M
- LAB – Standard Biotools Inc, $263M
- OSUR – OraSure Technologies Inc, $260M
- QSI – QuantumSi Inc, $245M
- QTRX – Quanterix Corp, $163M
- BNR – Burning Rock Biotech Ltd, $158M
- OPRX – OPTIMIZERx Corp, $156M
- CDXS – Codexis Inc, $145M
- SEER – Seer Inc, $121M
- MXCT – MaxCyte Inc, $104M
- DH – Definitive Healthcare Corp, $103M
- KEQU – Kewaunee Scientific Corporation, $97.9M
- RSSS – Research Solutions Inc, $67.5M
- CSBR – Champions Oncology Inc, $66.9M
- HYFT – ImmunoPrecise Antibodies Ltd., $60.8M
- RPID – Rapid Micro Biosystems Inc, $44.8M
- PRPO – Precipio Inc, $38.9M
- HBIO – Harvard Bioscience Inc, $37.5M
- DYAI – Dyadic International Inc, $17.8M
- TOMZ – TOMI Environmental Solutions Inc, $14.7M
- BNGO – Bionano Genomics Inc, $14.4M
- ADVB – Advanced Biomed Inc. Common Stock, $10.5M
- HCTI – Healthcare Triangle Inc, $6M
- CODX – Co-Diagnostics, Inc. Common Stock, $4.6M
- VIVS – VivoSim Labs, Inc., $2.6M
- ISPC – iSpecimen Inc, $2.6M
- BNBX – Applied DNA Sciences, Inc., $805,638
- PRPH – ProPhase Labs Inc, $155,925
- TTOO – T2 Biosystms Inc, $19,631
- THMO – Thermogenesis Holdings Inc, $1,584
- TBIO – Telesis Bio Inc., $177